Concentra Group had its Relative Strength (RS) Rating upgraded from 69 to 81 Thursday.
This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
History shows that the market's biggest winners typically have an RS Rating of at least 80 in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
Concentra Group is building a consolidation with a 24.80 buy point. See if the stock can break out in volume at least 40% higher than normal.
While EPS growth decreased in the prior quarter from -17% to -19%, the top line rose 6%, up from 3% in the previous report.
Concentra Group holds the No. 10 rank among its peers in the Medical-Managed Care industry group. Molina Healthcare, UnitedHealth Group and Cigna Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
